Health Cor Management, L.P. Bio N Tech Se Transaction History

Health Cor Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $5.13 Million - $8.59 Million	-23,690 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $4.88 Million - $10.6 Million	23,690 New	23,690 $6.47 Million
Q3 2020 Nov 16, 2020	SELL	$57.81 - $104.17 $29.1 Million - $52.5 Million	-503,920 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $19.4 Million - $33.6 Million	503,920 New	503,920 $33.6 Million

326

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.